The Importance of Coagulation Tests in Assessing Alcohol-Associated Liver Disease

A US study of high-risk drinking patterns suggests that deaths due to alcohol-associated liver disease are expected to double in the next twenty years. And this condition is associated with a range of complications - including hepatic encephalopathy, GI bleeding, and hepatorenal syndrome. So what if anything can we do to ensure that it is diagnosed and managed correctly?

To answer this and other important questions, please have a listen to this podcast interview with Professor Craig McClain, Chief of Research Affairs and Associate Vice President for Health Affairs and Research at the Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine. 

For more on alcohol-associated liver disease, visit BMJ Best Practice.

CM acts as a consultant for Nestlé, Durect, Allergan, Intercept, and DISCUS. He works for the Veterans Administration on a part-time basis, has received grants from the NIH and VAMC, and is working on the update of the AGC nutritional guideline.